Alpha-Lipoic Acid
Complete evidence review for diabetes management
Evidence Rating
Strong Evidence
Summary
Potent antioxidant that improves glucose uptake and reduces oxidative stress in peripheral nerves. Alpha-lipoic acid (ALA) has the strongest evidence for diabetic neuropathy symptom relief, with consistent results across multiple large clinical trials. It also shows modest benefits for insulin sensitivity and glucose control. The evidence is strongest for the 600mg/day dose administered intravenously, but oral supplementation at 600-1800mg/day also shows benefits.
-0.2 to -0.5%
A1C Reduction
600mg
daily
3
Key Studies
Neuropathy
symptom relief
What is Alpha-Lipoic Acid?
ALA is a powerful antioxidant that works in both water and fat-soluble environments. It regenerates other antioxidants (vitamins C and E, glutathione), improves glucose uptake in muscle cells, and reduces oxidative stress that damages nerves in diabetic neuropathy.
Clinical Evidence
Key studies supporting Alpha-Lipoic Acid's use in diabetes management:
Ziegler et al. (2006)
SYDNEY 2 Trial: 181 patients with diabetic neuropathy received 600mg, 1200mg, or 1800mg ALA daily for 5 weeks. All doses significantly improved neuropathy symptoms (pain, burning, numbness) compared to placebo. 600mg showed optimal risk-benefit profile.
Ziegler et al. (2011)
NATHAN 1 Trial: 460 patients with mild-to-moderate diabetic neuropathy. 4-year treatment with 600mg ALA daily improved neuropathy impairments and prevented progression. First long-term trial showing disease-modifying effects.
Jacob et al. (1999)
12-week trial in 72 patients with Type 2 diabetes. ALA 600mg twice daily increased insulin-stimulated glucose disposal by 27%. Significant improvement in insulin sensitivity.
Drug Interactions
Critical Warning: Always consult your healthcare provider before combining Alpha-Lipoic Acid with any diabetes medication.
| Medication | Risk Level | Details |
|---|---|---|
| Insulin | Moderate | ALA may enhance insulin sensitivity, potentially requiring dose adjustment. Monitor blood sugar closely when starting. |
| Metformin | Low Risk | May have additive glucose-lowering effects. Generally safe but monitor blood sugar. |
| Thyroid medications | Moderate | ALA may affect thyroid hormone levels. Take at least 4 hours apart from thyroid medication and monitor thyroid function. |
| Chemotherapy | Moderate | As an antioxidant, ALA might interfere with some chemotherapy drugs. Consult oncologist before use. |
Dosage
The most studied protocol is 600mg daily. Look for R-lipoic acid (R-ALA), the natural form, or racemic alpha-lipoic acid. R-ALA is more bioavailable but more expensive. Stabilized R-ALA products prevent degradation. Take on empty stomach for best absorption.
Product Dosage Comparison
| Product | Dose per Capsule | Matches Studies? |
|---|---|---|
| Clinical trials | 600mg 1-2x daily | |
| Doctor's Best ALA | 600mg per capsule | |
| NOW ALA | 600mg per capsule | |
| Nature's Bounty ALA | 200mg per capsule |
Side Effects
| Side Effect | Frequency | Management |
|---|---|---|
| Nausea | 5-10% | Take with food, start with lower dose |
| Skin rash | Rare | Discontinue if rash develops |
| Hypoglycemia | Rare | Monitor blood sugar, especially if taking diabetes medications |
Who Should NOT Take Alpha-Lipoic Acid
- Pregnant or breastfeeding women (insufficient safety data)
- People with thiamine (B1) deficiency
- Those scheduled for surgery (stop 2 weeks before)
- People undergoing chemotherapy (consult oncologist)
Recommended Products
The following products meet our quality criteria. Links are affiliate links - see our affiliate disclosure.
Doctor's Best Stabilized R-Lipoic Acid
- Form: Stabilized R-lipoic acid, 200mg per capsule
- Third-party testing: GMP certified facility
- Dosage matches studies: Yes
- Notable: Stabilized form prevents degradation, more bioavailable than regular ALA
- Price: ~$25 for 60 capsules
NOW Alpha Lipoic Acid 600mg
- Form: Racemic alpha-lipoic acid, 600mg per capsule
- Third-party testing: GMP certified
- Dosage matches studies: Yes
- Price: ~$20 for 120 capsules
Want the complete supplement-medication interaction chart?
Download our free 42-page Diabetes Management Handbook, which includes a printable interaction chart for 8 supplements across all major diabetes medications.
Get the Free HandbookReferences
- Ziegler et al. (2006). SYDNEY 2 Trial: 181 patients with diabetic neuropathy received 600mg, 1200mg, or 1800mg ALA daily for 5 weeks. PMID: 17065669
- Ziegler et al. (2011). NATHAN 1 Trial: 460 patients with mild-to-moderate diabetic neuropathy. PMID: 21715415
- Jacob et al. (1999). 12-week trial in 72 patients with Type 2 diabetes. PMID: 10333902